We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-36.21%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$23.8M
AUM Growth
-$50.3M
Cap. Flow
-$5.4M
Cap. Flow %
-22.65%
Top 10 Hldgs %
93.66%
Holding
25
New
6
Increased
4
Reduced
7
Closed
5

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$207K
2
CDTX
Cidara Therapeutics
CDTX
+$192K
3
ASMB icon
Assembly Biosciences
ASMB
+$164K
4
ABUS icon
Arbutus Biopharma
ABUS
+$163K
5
ACSF
American Capital Senior Floating, Ltd.
ACSF
+$141K

Top Sells

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$12.1M
2
IVTY
Invuity, Inc
IVTY
+$475K
3
SLRC icon
SLR Investment Corp
SLRC
+$318K
4
EVF
Eaton Vance Senior Income Trust
EVF
+$310K
5
OCSL icon
Oaktree Specialty Lending
OCSL
+$98K

Sector Composition

Rank Sector Weight
1 Healthcare 36.97%
2 Financials 2.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
1
Madrigal Pharmaceuticals
MDGL
$12.6B
$7.64M 32.03%
619,911
-439,207
-41% -$12.1M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$7.59M 31.85%
+37,251
New +$7.65M
CPXX
3
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$3.95M 16.59%
2,246,469
– –
ACAS
4
DELISTED
American Capital Ltd
ACAS
$946K 3.97%
68,621
-4,937
-7% -$67.5K
SRRA
5
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$688K 2.89%
1,143
– –
NSL
6
DELISTED
NUVEEN SENIOR INCM FD
NSL
$418K 1.75%
72,363
+1,845
+3% +$10.6K
PHD
7
DELISTED
Pioneer Floating Rate Fund
PHD
$321K 1.35%
29,603
-3,034
-9% -$33K
FRA icon
8
BlackRock Floating Rate Income Strategies Fund
FRA
$382M
$287K 1.2%
22,285
-1,603
-7% -$20.5K
JRO
9
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$258K 1.08%
26,314
-1,893
-7% -$18.6K
AGRX
10
DELISTED
Agile Therapeutics
AGRX
$225K 0.94%
12
– –
CDTX
11
DELISTED
Cidara Therapeutics
CDTX
$220K 0.92%
+641
New +$192K
SCM icon
12
Stellus Capital Investment Corp
SCM
$243M
$206K 0.86%
21,380
+225
+1% +$2.31K
BRK.B icon
13
Berkshire Hathaway Class B
BRK.B
$1.06T
$204K 0.86%
+1,546
New +$207K
MDLY
14
DELISTED
Medley Management Inc
MDLY
$187K 0.78%
3,289
-237
-7% -$15.3K
ICMB icon
15
Investcorp Credit Management BDC
ICMB
$12.4M
$150K 0.63%
15,125
+364
+2% +$3.92K
ASMB icon
16
Assembly Biosciences
ASMB
$512M
$136K 0.57%
+1,508
New +$164K
ABUS icon
17
Arbutus Biopharma
ABUS
$936M
$132K 0.55%
+29,762
New +$163K
ACSF
18
DELISTED
American Capital Senior Floating, Ltd.
ACSF
$129K 0.54%
+13,157
New +$141K
PFX icon
19
PhenixFIN
PFX
$80.3M
$126K 0.53%
835
-619
-43% -$94.4K
MDGL icon
20
CALL
Madrigal Pharmaceuticals
MDGL
$12.6B
$22K 0.09%
1,771
+142
+9% +$3.9K
EVF
21
Eaton Vance Senior Income Trust
EVF
$90.3M
– –
-52,889
Closed -$310K
GDX icon
22
CALL
VanEck Gold Miners ETF
GDX
$21.8B
– –
-31,733
Closed -$436K
OCSL icon
23
Oaktree Specialty Lending
OCSL
$1.09B
– –
-5,289
Closed -$98K
SLRC icon
24
SLR Investment Corp
SLRC
$725M
– –
-20,098
Closed -$318K
IVTY
25
DELISTED
Invuity, Inc
IVTY
– –
-33,905
Closed -$475K

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q4 2015 Portfolio in Review

As of Q4 2015, Caxton Corporation held 25 positions worth $23.8M, down 68% from $74.1M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Caxton Corporation withdrew a net $5.4M in Q4 2015, closing 5 positions and reducing 7 holdings. Its most notable exit was Invuity, Inc, an estimated $475K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 89% a quarter earlier, followed by Financials.

Against the trend, Caxton Corporation opened a new position in Berkshire Hathaway Class B worth $204K.

  • Caxton Corporation's largest Q4 2015 buy was Berkshire Hathaway Class B: 1,546 shares worth $204K.
  • Caxton Corporation added most to NUVEEN SENIOR INCM FD in Q4 2015, an estimated $10.6K increase.
  • Caxton Corporation's biggest Q4 2015 reduction was Madrigal Pharmaceuticals, cutting an estimated $12.1M.
  • Caxton Corporation fully exited Invuity, Inc in Q4 2015, selling an estimated $475K.
  • Caxton Corporation's ten largest holdings make up 94% of its $23.8M portfolio in Q4 2015.
  • Caxton Corporation opened 6 new positions and closed 5 in Q4 2015.
  • Caxton Corporation's portfolio value fell 68% quarter-over-quarter to $23.8M.

Based on Caxton Corporation's 13F filing for Q4 2015, filed 16 Feb 2016.